Abstract
Background
Small and remote acute ischemic lesions may occur in up to one-third of patients with spontaneous intracerebral hemorrhage (ICH). Possible mechanisms include cerebral embolism, small vessel disease, blood pressure variability and others. The embolic mechanism has not been adequately studied. Using transcranial Doppler (TCD), we assessed the incidence of spontaneous microembolic signals (MESs) in patients with acute ICH.
Methods
Twenty acute ICH patients were prospectively evaluated within 48 h of hospital admission. Clinical and imaging data were collected. Continuous TCD monitoring was performed in both middle cerebral arteries for a one-hour period on days 1, 3 and 7 of hospital admission. Monitoring was performed in the emergency room, ICU or ward, according to patient location. We compared the frequency and risk factors for MES in patients with ICH and in 20 age- and gender-matched controls without history of ischemic or hemorrhagic stroke.
Results
The mean age was 57.5 ± 14.1 years, and 60% were male. MESs were detected in 7 patients with ICH and in one control patient without ICH (35% vs 5%, p = 0.048). The frequency of MES on day 1 was 15% (3 of 20 patients), on day 3, 26% (5 of 19 patients) and on day 7, 37.5% (3 of 8 patients). Among patients with ICH, those with MES had a tendency to higher frequencies of dyslipidemia (83% vs 33%, p = 0.13) and lobar location of hemorrhages (71% vs 30%, p = 0.15). Two out of 6 patients with ICH who also underwent MRI had remote DWI lesions, of whom one showed MES on TCD.
Conclusion
Micro-embolic signals occur in over one-third of patients with ICH. Further research is needed to identify the sources of cerebral microembolism and their relationship with small acute infarcts in ICH.
Similar content being viewed by others
References
Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60.
Prabhakaran S, Gupta R, Ouyang B, et al. Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study. Stroke. 2010;41(1):89–94.
Menon RS, Burgess RE, Wing JJ, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol. 2012;71(2):199–205.
Ye X, Cai X, Nie D, et al. Stress-induced hyperglycemia and remote diffusion-weighted imaging lesions in primary intracerebral hemorrhage. Neurocrit Care. 2020;32(2):427–36. https://doi.org/10.1007/s12028-019-00747-y.
Kang DW, Han MK, Kim HJ, et al. New ischemic lesions coexisting with acute intracerebral hemorrhage. Neurology. 2012;79(9):848–55.
Auriel E, Gurol ME, Ayres A, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology. 2012;79(24):2335–411.
Arsava EM, Kayim-Yildiz O, Oguz KK, Akpinar E, Topcuoglu MA. Elevated admission blood pressure and acute ischemic lesions in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2013;22:250–4.
Tsai YH, Lee MH, Weng HH, Chang SW, Yang JT, Huang YC. Fate of diffusion restricted lesions in acute intracerebral hemorrhage. PLoS ONE. 2014;9(8):e105970.
Gioia LC, Kate M, Choi V, et al. Ischemia in intracerebral hemorrhage is associated with leukoaraiosis and hematoma volume, not blood pressure. Reduct Stroke. 2015;46(6):1541–7.
Wu B, Yao X, Lei C, Liu M, Selim MH. Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage. Neurology. 2015;85(23):2045–52.
Ye X, Gao T, Xu X, et al. Factors associated with remote diffusion-weighted imaging lesions in spontaneous intracerebral hemorrhage. Front Neurol. 2018;9:209.
Boulanger M, Schneckenburger R, Join-Lambert C, et al. Diffusion-weighted imaging hyperintensities in subtypes of acute intracerebral hemorrhage. Stroke. 2019;50:135–42.
Gregoire SM, Charidimou A, Gadapa N, et al. Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain. 2011;134(8):2376–86.
Kidwell CS, Rosand J, Norato G, et al. Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. Neurology. 2017;88:782–8.
Revel-Mouroz P, Viguier A, Cazzola V, et al. Acute ischaemic lesions are associated with cortical superficial siderosis in spontaneous intracerebral hemorrhage. Eur J Neurol. 2019;26:660–6.
Garg RK, Liebling SM, Maas MB, Nemeth AJ, Russell EJ, Naidech AM. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke. 2012;43:67–71.
Prabhakaran S, Naidech AM. Ischemic brain injury after intracerebral hemorrhage: a critical review. Stroke. 2012;43(8):2258–63.
Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116–21.
Smith EE, Fitzsimmons AL, Nogueira RG, Singhal AB. Spontaneous hyperacute postischemic hemorrhage leading to death. J Neuroimaging. 2004;14(4):361–4.
Al-Shahi Salman R, Dennis MS, Sandercock PAG, et al. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet. 2019;393:2613–23.
Ringelstein EB, Droste DW, Babikian VL, et al. Consensus on microembolus detection by TCD. Stroke. 1998;29(3):725–9.
King A, Bath PMW, Markus HS. Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial. Stroke. 2011;42:650–5.
Safouris A, Krogias C, Sharma VK, et al. Statin pretreatment and microembolic signals in large artery atherosclerosis. Arterioscler Thromb Vasc Biol. 2017;37:1415–22.
Wong KSL, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489–97.
Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111:2233–40.
Reza M, Velayati A, Chambers BR, Mashhadi H. Microembolic signals in subarachnoid hemorrhage q. J Clin Neurosci. 2009;16(3):390–3. https://doi.org/10.1016/j.jocn.2008.05.013.
Romano JG, Forteza AM, Concha M, et al. Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50(5):1026–31.
Babikian VL. Basic identification criteria of doppler microembolic signals. Stroke. 1995;26(6):1123. https://doi.org/10.1161/01.STR.26.6.1123.
Topçuoǧlu MA, Arsava EM. Neurosonology of emboli detection and monitoring. Turk Beyin Damar Hast Derg. 2012;18:59–71.
Blaser T, Glanz W, Krueger S, Wallesch CW, Kropf S, Goertler M. Time period required for transcranial Doppler monitoring of embolic signals to predict recurrent risk of embolic transient ischemic attack and stroke from arterial stenosis. Stroke. 2004;35:2155–9.
Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012;43(10):2592–7.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.
Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score. Stroke. 2001;32:891–7.
Banks JL, Marotta CA. Outcomes validity and reliability of the modified rankin scale: implications for stroke clinical trials—a literature review and synthesis. Stroke. 2007;38:1091–6.
Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007;38(11):2979–84.
Topcuoglu MA, Rocha EA, Siddiqui AK, et al. Isolated upper limb weakness from ischemic stroke: mechanisms and outcome. J Stroke Cerebrovasc Dis. 2018;27(10):2712–9.
Kamel H, Navi BB, Merkler AE, et al. Reclassification of ischemic stroke etiological subtypes on the basis of high-risk nonstenosing carotid plaque. Stroke. 2020;51:504–10.
Ricarte IF, Dutra LA, Barsottini OGP, et al. Transcranial Doppler findings in antiphospholipid syndrome. Lupus. 2019;28:483–91.
Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thromb Res. 2005;115:367–73.
Wilkinson DA, Pandey AS, Thompson BG, Keep RF, Hua Y, Xi G. Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology. 2018;134:240–8.
Siebler M, Nachtmann A, Sitzer M, et al. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke. 1995;26:2184–6.
Birnbaum L, Rundek T, Alexandrov AV. Risk stratification of patients with asymptomatic carotid artery stenosis: transcranial Doppler-based evaluation of asymptomatic cerebral microemboli. In: Moussa I, Rundek T, Mohr JP, editors. Asymptomatic carotid artery stenosis: a primer on risk stratification and management. Boca Raton: CRC Press; 2007.
Orlandi G, Fanucchi S, Sartucci F, Murri L. Can microembolic signals identify unstable plaques affecting symptomatology in carotid stenosis? Stroke. 2002;33:1744.
Goertler M, Blaser T, Krueger S, Hofmann K, Baeumer M, Wallesch CW. Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry. 2002;72:338–42.
Ciller CA, Ciller AM, Landreneau F. Detection of emboli after surgery for intracerebral aneurysms. Neurosurgery. 1998;42:490–4.
Ghandehari K. Microembolic signal monitoring in patients with acute stroke. Arch Iran Med. 2002;5(2):94–6.
King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke. 2009;40(12):3711–7.
Russell D. The detection of cerebral emboli using Doppler ultrasound. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York, NY: Raven Press Publishers; 1992. p. 207–13.
Funding
Dr. Eva Rocha’s visiting scholarship at Massachusetts General Hospital and Harvard Medical School, Boston, was sponsored by the Capes Foundation, Ministry of Education, Brazil (Grant No. 88881.133101/2016-01).
Author information
Authors and Affiliations
Contributions
All authorship requirements have been met, and the final manuscript was approved by all authors
Corresponding author
Ethics declarations
Conflicts of Interest
Authors declare that they have no conflict of interest.
Ethical Approval
This study adhered to ethical guidelines, was approved by the Institutional Review Board (IRB), and all patients signed informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rocha, E.A., Rocha, F., Deliberalli, I. et al. Cerebral Microembolism in Intracerebral Hemorrhage: A Prospective Case–Control Study. Neurocrit Care 34, 547–556 (2021). https://doi.org/10.1007/s12028-020-01073-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-01073-4